Simulations Plus

Simulations Plus Change in Working Capital

Delisted·Oct 7, 2026

The Change in Working Capital of Simulations Plus (SLP) as of Nov 11, 2026 is -2.59 M USD. In the previous year, Change in Working Capital was -4.21 M USD — a change of -38.60% (higher).

Change in Working Capital

-2.59 MUSD

YoY

-38.60%

Last updated:

Change in Working Capital of Simulations Plus is 2025 -2.59 M USD. Change in Working Capital of Simulations Plus was 2024 -4.21 M USD. It decreases by -38.60% higher compared to the previous year.

The Simulations Plus Change in Working Capital history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Change in Working Capital
Date
Change in Working Capital
Jan 1, 2018
-1.50 M USD
Jan 1, 2019
-582,955.00 USD
Jan 1, 2020
-2.78 M USD
Jan 1, 2021
974,000.00 USD
Jan 1, 2022
-2.62 M USD
Jan 1, 2023
5.10 M USD
Jan 1, 2024
-4.21 M USD
Jan 1, 2025
-2.59 M USD
The Simulations Plus Change in Working Capital history
YEARChange in Working CapitalYoY
-2.59 MUSD-38.60%
-4.21 MUSD-182.54%
5.10 MUSD-294.77%
-2.62 MUSD-368.99%
974,000.00USD-134.99%
-2.78 MUSD+377.45%
-582,955.00USD-61.11%
-1.50 MUSD-1.81%
-1.53 MUSD-14.77%
-1.79 MUSD-288.28%
951,275.00USD-575.65%
-199,996.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Change in Working Capital of Simulations Plus is -2.59 M USD in 2025.

Change in Working Capital of Simulations Plus changed from -4.21 M USD to -2.59 M USD, representing a -38.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Change in Working Capital Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

Change in working capital reflects the period-over-period change in current assets minus current liabilities. It impacts operating cash flow significantly.

Change in Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Change in Working Capital's Simulations Plus historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Simulations Plus

All Key Metrics — Simulations Plus